Yale Catriona Insider Trades

Insider Trading History

Track insider trading activity for Yale Catriona. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$27M 493,367 shares
$54.65
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Nov 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$447k 8,266 shares
$54.03
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $4.09M 74,800 shares
Last Trade
Nov 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$447k 8,266 shares
$54.03
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $4.96M 90,829 shares
Last Trade
Sep 11, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$28.4k 659 shares
$43.02
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $5.07M 92,830 shares
Last Trade
Jul 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$530k 10,000 shares
$52.95
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $7.17M 131,205 shares
Last Trade
Jul 16, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$536k 10,000 shares
$53.60
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $5.55M 101,488 shares
Last Trade
Jul 16, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$536k 10,000 shares
$53.60
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $5M 91,488 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.5k 890 shares
$53.36
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $4.95M 90,598 shares
Last Trade
Jun 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$89.6k 1,633 shares
$54.84
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $5.59M 102,231 shares
Last Trade
Jun 16, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$558k 10,000 shares
$55.75
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Jun 16, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$558k 10,000 shares
$55.75
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $5.25M 96,021 shares
Last Trade
Jun 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$542k 10,000 shares
$54.23
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $5.04M 92,231 shares
Last Trade
Jun 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$151k 2,803 shares
$54.00
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $5.59M 102,197 shares
Last Trade
May 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$393k 10,000 shares
$39.30
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $547k 10,000 shares
Last Trade
May 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$400k 10,000 shares
$39.96
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $5.74M 105,034 shares
Last Trade
May 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$400k 10,000 shares
$39.96
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $1.09M 20,000 shares
Last Trade
Apr 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$345k 9,073 shares
$38.08
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $5.26M 96,234 shares
Last Trade
Apr 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$344k 9,073 shares
$37.91
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $5.69M 104,107 shares
Last Trade
Apr 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$345k 9,073 shares
$38.08
$54.65
Akero Therapeutics
Akero Therapeutics AKRO
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Mar 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$448k 10,000 shares
$44.82
$54.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up